About Us
As a Swiss pharmaceutical company headquartered in Zurich, we develop, manufacture and internationally market well-proven and innovative pharmaceuticals in novel drug delivery forms.
We are a leader in advanced drug delivery technologies with a focus on modified release oral forms, and oral dispersible forms, for which we also hold patents.
With a clear focus on selected markets in the Middle East, Africa, the CIS Region, and Latin America, we are operating in some of the most dynamic countries of the world. Our in-depth knowledge of our markets enables us to adapt to local needs, however challenging.
We make and provide quality medicines having patients in mind. We are dynamic and open-minded – we seize opportunities and stay strong, even if it gets difficult.
That’s how we really make a difference. And that is the spirit we bring to all our fields of business.
Key Figures
Group sales
€400m
As of December 31, 2019
Sales % in emerging markets
80%
As of December 31, 2019
Employees
2,400
As of December 31, 2019
Manufacturing sites
6
Switzerland (3), Ukraine, Estonia and South Africa
Regional offices
5
Kiev, Dubai, Johannesburg, Panama and Moscow